PT Itama Ranoraya Tbk

IDX:IRRA Stock Report

Market Cap: Rp600.1b

Itama Ranoraya Past Earnings Performance

Past criteria checks 1/6

Itama Ranoraya's earnings have been declining at an average annual rate of -21.9%, while the Healthcare industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 8.8% per year. Itama Ranoraya's return on equity is 2.1%, and it has net margins of 1%.

Key information

-21.9%

Earnings growth rate

-21.8%

EPS growth rate

Healthcare Industry Growth14.1%
Revenue growth rate8.8%
Return on equity2.1%
Net Margin1.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Itama Ranoraya makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

IDX:IRRA Revenue, expenses and earnings (IDR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24974,7689,995137,4550
30 Jun 24805,7601,422122,6230
31 Mar 24747,1133,033115,5670
31 Dec 23696,3045,198108,4260
30 Sep 23504,79122,79783,6110
30 Jun 23536,36524,84083,0180
31 Mar 23580,78133,15079,8970
31 Dec 22753,57248,00583,1940
30 Sep 22787,95367,72364,2130
30 Jun 221,196,70997,19480,3080
31 Mar 221,361,406112,57888,6310
31 Dec 211,319,728112,15584,6700
30 Sep 211,509,169136,41692,0970
30 Jun 211,049,647107,56365,1210
31 Mar 21765,33979,21945,7530
31 Dec 20563,88860,52238,1210
30 Sep 20293,85636,06914,0350
30 Jun 20299,23432,14915,3720
31 Mar 20282,07733,50015,7200
31 Dec 19281,75233,20514,4770
31 Mar 19244,42729,87210,8430
31 Dec 18265,62932,26111,2410
31 Dec 17225,20423,9767,7100
31 Dec 1612,9927071,0230

Quality Earnings: IRRA has high quality earnings.

Growing Profit Margin: IRRA's current net profit margins (1%) are lower than last year (4.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: IRRA's earnings have declined by 21.9% per year over the past 5 years.

Accelerating Growth: IRRA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: IRRA had negative earnings growth (-56.2%) over the past year, making it difficult to compare to the Healthcare industry average (-1.8%).

Return on Equity

High ROE: IRRA's Return on Equity (2.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 01:19
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PT Itama Ranoraya Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution